Target intelligence / Profile preview

EVA1C pseudogene 2 (EVA1CP2)

Target
EVA1CP2
Molecular classification
Other
01

Overview

EVA1C pseudogene 2 (EVA1CP2) is annotated as a pseudogene, meaning it is a genomic DNA sequence resembling a gene but typically lacking the ability to code for a functional protein. There is no evidence EVA1CP2 is a receptor, enzyme, transporter, or druggable target. Most available information and associated biological functions refer to the EVA1C protein (Eva-1 homolog C), which is a transmembrane protein involved in axon guidance, immune cell infiltration, and possibly certain disease conditions, not to EVA1CP2. No functional, disease, or drug data exist specifically for EVA1CP2 in the scientific literature or gene databases. EVA1CP2 is classified as a pseudogene, not an active or functional gene. There is no evidence that EVA1CP2 produces a functional protein or plays a role as a therapeutic target. This target is likely inappropriate for therapeutic or pharmacological research purposes due to its annotation as a pseudogene. All available disease, functional, or pharmacological data refer to the actual EVA1C gene/protein, not the pseudogene EVA1CP2.

Other names
EVA1CP2

Beyond the preview

Go deeper on EVA1C pseudogene 2 (EVA1CP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EVA1C pseudogene 2 (EVA1CP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call